Biolevox(TM) HA 2.2%
Products
Information
Biolevox(TM) HA 2.2% is a hyaluronic acid (HA) gel designed for a three intra-articular injection into the osteoarthritis (OA) affected in order to ameliorate symptoms of the osteoarthritis (OA) in synovial joint. Designed HA-based gel contains 44 mg of hyaluronate in 2 ml pre-filled syringe. The combination of high concentration of hyaluronate and optimally high molecular weight creates gel characterized with optimally high viscosity and elasticity. With those properties Biolevox(TM) HA 2.2% is an ideal solution for a triple intra-articular injection viscosupplementation therapy.
All Categories
InjectablesMedical Devices and Medical PackagingRegenerative Medicine
Main Categories
Biopharmaceutical ProductsFinished Dosage Forms (Products)Packaging Materials and Equipment (Products)
Distribution Areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
Poland
